Wednesday, March 26, 2014

Dr. Michelle Whirl-Carrillo promoted to Associate Director of PharmGKB

›
PharmGKB is delighted to announce the promotion of Dr. Michelle Whirl-Carrillo to Associate Director. Dr. Whirl-Carrillo joined PharmGKB i...
Wednesday, March 19, 2014

New PharmGKB VIP Summary: SLC22A1 (OCT1)

›
Solute carrier family 22 (organic cation transporter), member 1 ( SLC22A1 , also called OCT1) is a polyspecific cationic transporter mediati...
Tuesday, March 11, 2014

Canadian pharmacogenomics group recommends genetic testing for patients prescribed carbamazepine

›
In a recent article published online in the journal Epilepsia , the Canadian Pharmacogenomics Network for Drug Safety ( CPNDS ) has recomme...
Monday, March 10, 2014

American Society of Health-System Pharmacists to host live webinar on CPIC

›
The American Society of Health-System Pharmacists (ASHP) will be hosting a live webinar on Tuesday, April 15th from 2:00 - 3:00 pm EST  dis...
Thursday, March 6, 2014

Additional CFTR variants for ivacaftor treatment approved by FDA

›
The drug label for ivacaftor was recently amended and has been approved by the FDA . Ivacaftor was originally indicated only for use in C...
Wednesday, March 5, 2014

CPIC guideline for ivacaftor therapy based on CFTR genotype of cystic fibrosis patients

›
Cystic fibrosis (CF) therapy has traditionally been based on the treatment of symptoms and infections, rather than targeting the un...
Friday, February 28, 2014

CPIC abacavir & HLA-B guideline update published

›
CPIC has extensively reviewed the literature and concluded no changes are required to the therapeutic recommendations of the abacavir dosin...